ReviewClinical rheumatology2026
Fibromyalgia in men: beyond invisibility-a biopsychosocial and clinical perspective in rheumatology.
Review in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fibromyalgia is a chronic pain syndrome traditionally perceived as a predominantly female condition, although growing evidence suggests that this view may partly reflect diagnostic and sociocultural biases rather than true epidemiological differences. This perspective critically examines fibromyalgia in men as an underrecognized and understudied clinical entity. The authors propose an integrative conceptual framework in which the invisibility of men with fibromyalgia emerges from the interaction between sociocultural barriers to healthcare-seeking, clinician-related diagnostic bias, and heterogeneous symptom expression influenced by biological and psychosocial factors. Men may delay seeking medical care due to cultural expectations of masculinity and frequently encounter skepticism regarding symptoms such as diffuse pain, fatigue, and psychological distress. Although core symptoms are shared across sexes, men may differ in coping strategies, illness perception, and healthcare interaction. Emerging evidence also suggests possible neurophysiological and functional alterations, including small fiber pathology, reduced muscular strength, gait impairments, and psychological comorbidities. However, current evidence remains limited by small samples and methodological heterogeneity. The article argues that understanding fibromyalgia in men is essential not to establish rigid sex-specific phenotypes, but to improve diagnostic sensitivity, promote biopsychosocial and gender-sensitive care, and expand the understanding of heterogeneity within chronic pain disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.